Molecular, genetic, and pharmacological advances in type 2 diabetes (2015-2025)
{{output}}
Type 2 diabetes (T2D) is a multifactorial metabolic disorder driven by the interplay of insulin resistance, β-cell dysfunction, and complex genetic and epigenetic factors. Over the past decade (2015-2025), advances in molecular biology, genomics, and pharmaco... ...
